LANDUCCI, ELISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.651
EU - Europa 6.081
AS - Asia 3.384
SA - Sud America 378
Continente sconosciuto - Info sul continente non disponibili 149
AF - Africa 111
OC - Oceania 46
Totale 17.800
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.500
PL - Polonia 2.321
RU - Federazione Russa 1.328
IT - Italia 1.127
SG - Singapore 980
CN - Cina 867
HK - Hong Kong 533
IE - Irlanda 329
BR - Brasile 294
VN - Vietnam 292
SE - Svezia 258
KR - Corea 249
FR - Francia 153
FI - Finlandia 133
DE - Germania 128
IN - India 96
GB - Regno Unito 93
CA - Canada 90
BD - Bangladesh 67
CH - Svizzera 65
JO - Giordania 59
TR - Turchia 51
ID - Indonesia 50
AU - Australia 46
NL - Olanda 46
JP - Giappone 43
MX - Messico 30
UA - Ucraina 29
AR - Argentina 26
CI - Costa d'Avorio 22
ZA - Sudafrica 21
NG - Nigeria 19
ES - Italia 18
IQ - Iraq 18
PK - Pakistan 14
BE - Belgio 13
CO - Colombia 13
EC - Ecuador 12
PY - Paraguay 11
EG - Egitto 10
CR - Costa Rica 8
PH - Filippine 8
AE - Emirati Arabi Uniti 7
MA - Marocco 7
UZ - Uzbekistan 7
BJ - Benin 6
CL - Cile 6
MY - Malesia 6
SA - Arabia Saudita 6
GT - Guatemala 5
JM - Giamaica 5
LB - Libano 5
LT - Lituania 5
NP - Nepal 5
PE - Perù 5
VE - Venezuela 5
AT - Austria 4
BG - Bulgaria 4
BO - Bolivia 4
BY - Bielorussia 4
CZ - Repubblica Ceca 4
DZ - Algeria 4
MU - Mauritius 4
TN - Tunisia 4
TW - Taiwan 4
DK - Danimarca 3
EU - Europa 3
HU - Ungheria 3
IL - Israele 3
KE - Kenya 3
PT - Portogallo 3
SN - Senegal 3
TT - Trinidad e Tobago 3
AL - Albania 2
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GP - Guadalupe 2
HN - Honduras 2
NO - Norvegia 2
SV - El Salvador 2
TH - Thailandia 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
BF - Burkina Faso 1
BH - Bahrain 1
CU - Cuba 1
GM - Gambi 1
GR - Grecia 1
IR - Iran 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MG - Madagascar 1
MM - Myanmar 1
MO - Macao, regione amministrativa speciale della Cina 1
Totale 17.648
Salva come PNG Salva come JPEG
Città #
Warsaw 2.317
Santa Clara 1.458
Ashburn 924
Singapore 697
Fairfield 507
Hong Kong 467
San Jose 342
Chandler 327
Dublin 325
Woodbridge 245
Seoul 242
Seattle 224
Council Bluffs 212
Beijing 204
Cambridge 191
Houston 185
Wilmington 182
Milan 165
Hefei 161
Florence 153
Ann Arbor 144
The Dalles 132
Buffalo 123
Los Angeles 116
Dallas 106
Lawrence 86
Altamura 83
Rome 82
Ho Chi Minh City 77
Lauterbourg 77
Princeton 73
Moscow 67
Brunswick 60
Hanoi 59
Shanghai 57
Phoenix 56
Bern 54
Boston 53
Helsinki 52
Munich 50
New York 45
Melbourne 43
San Diego 42
Jakarta 41
Dearborn 40
Paris 39
Tokyo 39
Boardman 38
Medford 37
Dong Ket 36
Mumbai 35
Naples 33
Turin 32
Kent 31
São Paulo 31
Turku 28
Jacksonville 25
Clifton 24
Abidjan 22
Frankfurt am Main 22
London 22
Chicago 21
Toronto 21
Orem 20
Redondo Beach 20
Atlanta 19
Bologna 19
Falls Church 18
Guangzhou 16
Lappeenranta 16
Washington 16
Abuja 15
Chennai 15
San Francisco 15
Da Nang 13
Figino 13
Montreal 13
Brasília 12
Brussels 12
Miano 12
Bengaluru 11
Haiphong 11
Belo Horizonte 10
Johannesburg 10
Palermo 10
Brooklyn 9
Charlotte 9
Hillsboro 9
Las Vegas 9
Norwalk 9
Yubileyny 9
Denver 8
Dhaka 8
Fort Wayne 8
Genoa 8
Izmir 8
Manchester 8
Modena 8
North Bergen 8
Salt Lake City 8
Totale 12.324
Salva come PNG Salva come JPEG
Nome #
Anticonvulsant and Neuroprotective Effects of the Thyroid Hormone Metabolite 3-Iodothyroacetic Acid. 450
3-Iodothyroacetic acid (TA1), a by-product of thyroid hormone metabolism, reduces the hypnotic effect of ethanol without interacting at GABA-A receptors. 383
Histamine mediates behavioural and metabolic effects of 3-iodothyroacetic acid, an endogenous end product of thyroid hormone metabolism 374
Solid lipid nanoparticles for delivery of andrographolide across the blood-brain barrier: in vitro and in vivo evaluation. 354
Neuroprotective effects of topiramate and memantine in combination with hypothermia in hypoxic-ischemic brain injury in vitro and in vivo 353
Arrays of MicroLEDs and Astrocytes: Biological Amplifiers to Optogenetically Modulate Neuronal Networks Reducing Light Requirement 343
The pro-healing effect of exendin-4 on wounds produced by abrasion in normoglycemic mice 340
In the brain of mice,3-iodothyronamine(T1AM) is converted into 3-iodothyroaceticacid(TA1) and it is included within the signaling network connecting thyroid hormone metabolites with histamine 319
Pharmacological effects of 3-iodothyronamine (T1AM) in mice include facilitation of memory acquisition and retention and reduction of pain threshold 317
Stealth and Cationic Nanoliposomes as Drug Delivery Systems to Increase Andrographolide BBB Permeability 314
Differential role of mGlu1 and mGlu5 receptors in rat hippocampal slice models of ischemic tolerance 310
Prokineticins are neuroprotective in models of cerebral ischemia and ischemic tolerance in vitro 305
Thyroid Hormone, Thyroid Hormone Metabolites and Mast Cells: A Less Explored Issue. 300
Interplay between histone acetylation/deacetylation and poly(ADPribosyl)ation in the development of ischemic tolerance in vitro 296
N-(3-Ethoxy-phenyl)-4-pyrrolidin-1-yl-3-trifluoromethyl-benzamide (EPPTB) prevents 3-iodothyronamine (T1AM)-induced neuroprotection against kainic acid toxicity 291
Neuroprotective effects of mGluR5 activation through the PI3K/Akt pathway and the molecular switch of AMPA receptors 285
Brain histamine modulates the antidepressant-like effect of the 3-iodothyroacetic acid (TA1) 279
Glutamate receptor and transporter modifications in rat organotypic hippocampal slice cultures exposed to oxygen-glucose deprivation: The contribution of cyclooxygenase-2 269
Glutamate Receptor-Mediated Neurotoxicity in a Model of Ethanol Dependence and Withdrawal in Rat Organotypic Hippocampal Slice Cultures 268
Central Effects of 3-Iodothyronamine Reveal a Novel Role for Mitochondrial Monoamine Oxidases. 261
Chitosan coated human serum albumin nanoparticles: A promising strategy for nose-to-brain drug delivery 261
A new ophthalmic formulation containing antiseptics and dexpanthenol: In vitro antimicrobial activity and effects on corneal and conjunctival epithelial cells 258
Formulation of Nanomicelles to Improve the Solubility and the Oral Absorption of Silymarin 255
The gliadin peptide 31-43 exacerbates kainate neurotoxicity in epilepsy models 251
Niosomal Formulation of a Lipoyl-Carnosine Derivative Targeting TRPA1 Channels in Brain 243
Bicuculline Reverts the Neuroprotective Effects of Meloxicam in an Oxygen and Glucose Deprivation (OGD) Model of Organotypic Hippocampal Slice Cultures 240
Enhanced dissolution, permeation and oral bioavailability of aripiprazole mixed micelles: In vitro and in vivo evaluation 240
Anti-Inflammatory Properties of Cannabidiol and Beta-Caryophyllene Alone or Combined in an In Vitro Inflammation Model 239
Evaluation of Conventional and Hyaluronic Acid-Coated Thymoquinone Liposomes in an In Vitro Model of Dry Eye 226
BRAIN-TARGETED DELIVERY OF ANDROGRAPHOLIDE USING SOLID LIPID NANOPARTICLES: IN VITRO AND IN VIVO EVALUATION 221
Antiseptics and the Ocular Surface: In Vitro Antimicrobial Activity and Effects on Conjunctival and Corneal Epithelial Cells of a New Liposomal Ocular Spray Containing Biosecur Citrus Extract 217
3-Iodothyronamine Affects Thermogenic Substrates' Mobilization in Brown Adipocytes. 213
The Protective Effect of CBD in a Model of In Vitro Ischemia May Be Mediated by Agonism on TRPV2 Channel and Microglia Activation 210
Using organotypic hippocampal slice cultures to gain insight into mechanisms responsible for the neuroprotective effects of meloxicam: A role for gamma aminobutyric and endoplasmic reticulum stress 206
Ethanol Toxicity During Brain Development: Alterations of Excitatory Synaptic Transmission in Immature Organotypic Hippocampal Slice Cultures 204
Safety and efficacy of topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia (NeoNATI): a feasibility study 197
CB1 receptors and post-ischemic brain damage: studies on the toxic and neuroprotective effects of cannabinoids in rat organotypic hippocampal slices 194
PARP-1 activation causes neuronal death in the hippocampal CA1 region by increasing the expression of Ca2+-permeable AMPA receptors 194
Co-expression of the SARS-CoV-2 entry receptors ACE2 and TMPRSS2 in healthy human conjunctiva 192
Neuroprotective effects of thymoquinone by the modulation of ER stress and apoptotic pathway in in vitro model of excitotoxicity. 190
Cannabidiol inhibits microglia activation and mitigates neuronal damage induced by kainate in an in-vitro seizure model 189
Differential mechanisms of tolerance induced by NMDA and DHPG preconditioning 188
Enhanced Neuroprotective Effects of Panax Ginseng G115® and Ginkgo Biloba GK501® Combinations In Vitro Models of Excitotoxicity 183
Neuroprotective effects of cannabidiol but not Δ9-tetrahydrocannabinol in rat hippocampal slices exposed to oxygen-glucose deprivation: studies with Cannabis extracts and selected cannabinoids. 182
Evaluation of the increase of the thymoquinone permeability formulated in polymeric micelles: in vitro test and in vivo toxicity assessment in Zebrafish embryos. 180
Rat hippocampal slice culture models for the evaluation of neuroprotective agents. 179
Mild activation of poly(ADP-ribose) polymerase (PARP) is neuroprotective in rat hippocampal slice models of ischemic tolerance 178
Involvement of endocannabinoid signaling in the neuroprotective effects of subtype 1 metabotropic glutamate receptor antagonists in models of cerebral ischemia 175
Virtual screening and in vitro experiments highlight cannabidiol as a drug-like phosphodiesterase 9 inhibitor 174
Beneficial effects of CHF6467, a modified human nerve growth factor, in experimental neonatal hypoxic–ischaemic encephalopathy 173
Neuroprotection by group I mGlu receptors in a rat hippocampal slice model of cerebral ischemia is associated with the PI3K–Akt signaling pathway: A novel postconditioning strategy? 173
Preparation of liposomal formulations for ocular delivery of thymoquinone: in vitro evaluation in HCEC-2 e HConEC cells. 173
DHPG and NMDA preconditioning induce ischemic tolerance with differential mechanisms 172
Interplay between group I mGlu and the endocannabinoid system in the hippocampus: studies in models of cerebral ischemia 169
Neuronal and Astrocytic Morphological Alterations Driven by Prolonged Exposure with Δ9-Tetrahydrocannabinol but Not Cannabidiol 166
Tolerance Induced by (S)-3,5-Dihydroxyphenylglycine Postconditioning is Mediated by the PI3K/Akt/GSK3β Signalling Pathway in an In Vitro Model of Cerebral Ischemia 165
Development and Blood–Brain Barrier Penetration of Nanovesicles Loaded with Cannabidiol. 164
An electrophysiological study of the mGlu1 receptors ability to modulate endocannabinoids production and inhibitory synaptic transmission in the CA1 hippocampal area 162
Virtual Screening-Accelerated Discovery of a Phosphodiesterase 9 Inhibitor with Neuroprotective Effects in the Kainate Toxicity In Vitro Model 161
Nerve growth factor (NGF) mimetics modulate ischemic brain damage 159
mGlu1 receptors and endocannabinoids: neuroprotection studies in an in vitro model of cerebral ischemia 157
Applications of innovative technologies to the antipsychotics delivery. 154
Prolonged incubation with Δ9-tetrahydrocannabinol but not with cannabidiol induces synaptic alterations and mitochondrial impairment in immature and mature rat organotypic hippocampal slices 152
The Neuroprotective Effects of mGlu1 Receptor Antagonists Are Mediated by an Enhancement of GABAergic Synaptic Transmission via a Presynaptic CB1 Receptor Mechanism 150
Experimental Models for Testing the Efficacy of Pharmacological Treatments for Neonatal Hypoxic-Ischemic Encephalopathy 149
Nerve Growth Factor mimetics with neuroprotective activity in ischemic brain damage 149
Neurotoxicity of Unconjugated Bilirubin in Mature and Immature Rat Organotypic Hippocampal Slice Cultures 148
Preconditioning With NMDA and DHPG Induces Ischemic Tolerance With Differential Mechanisms In An In Vitro Hippocampal Slice Model Of Excitotoxicity 145
Endocannabinoids play a crucial role in the mechanisms of mGlu1-mediated neuroprotection in models of cerebral ischemia. 143
Neuroprotective effects of the novel glutamate transporter inhibitor (-)-3-hydroxy-4,5,6,6a-tetrahydro-3aH-pyrrolo[3,4-d]-isoxazole-4-carboxylic acid, which preferentially inhibits reverse transport (glutamate release) compared with glutamate reuptake 142
Dual action of sphingosine 1-phosphate pathway in in vitro models of global cerebral ischemia 137
Preconditioning with NMDA, but not DHPG, induces tolerance to excitotoxicity by internalization of AMPA receptors. 137
Interplay between group I mGlu receptors and the endocannabinoid system in the CA1 hippocampal area: studies in models of cerebral ischemia 133
Mild activation of ionotropic and metabotropic glutamate receptors induces ischemic tolerance with differential mechanisms in rat organotypic hippocampal slices 128
Phenomic Microglia Diversity as a Druggable Target in the Hippocampus in Neurodegenerative Diseases 127
Novel 3-carboxy- and 3-phosphonopyrazoline amino acids as potent and selective NMDA receptor antagonists: design, synthesis, and pharmacological characterization 126
Cannabidiol preferentially binds TRPV2: a novel mechanism of action 125
Interplay between mGlu1 and CB1 receptors in the postischemic CA1 hippocampal area: Neuroprotection and anatomical studies. 116
Interplay between group I mGlu receptors and the endocannabinoid system in the CA1 hippocampal area: an electrophysiological study 114
Neuroprotection following postconditioning via group I mGlu receptor activation is coupled to the PI3K/Akt/GSK3β signalling pathway in a rat organotypic hippocampal slice model of cerebral ischemia 109
Preconditioning with NMDA and DHPG induces ischemic tolerance with differential mechanisms in an in vitro hippocampal slice model 108
MPP+-dependent inhibition of Ih reduces spontaneous activity and enhances EPSP summation in nigral dopamine neurons 101
NMDA and DHPG preconditioning induce ischemic tolerance with differential mechanisms in rat organotypic hippocampal slices 97
Improved super-bright microLEDs for bi-dimensional optogenetic applications and opto-electronic retinal prosthesis. 96
8-Amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives hybridized with antioxidants: new highly potent and selective human A2A adenosine receptor antagonists as useful agents against cerebral ischemia 85
Interactions between mGlu1 receptors and endocannabinoids in the pathophysiology of hippocampal post-ischemic neuronal death 79
Article Vitamin D Nanoliposomes to Improve Solubility, Stability, and Uptake Across Intestinal Barrier 63
Sex-Dependent Long-Term Neurobehavioral Recovery in Experimental Neonatal Hypoxic-Ischemic Encephalopathy 42
Cutamesine attenuates hippocampal damage via sigma-1 receptor activation following oxygen-glucose deprivation in vitro 41
Ellagic acid-loaded galactosylated liposomes: an efficient strategy for counteracting senescence in mixed primary glial cells 12
Structure‐Guided Optimization of PDE9A Inhibitors Tackling Neuroinflammation: A Combined Computational and In Vitro Study 8
Totale 17.800
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.876
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.876
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022472 0 0 36 18 14 47 36 35 29 32 88 137
2022/20231.523 117 261 79 88 111 252 191 91 198 14 49 72
2023/2024646 20 77 89 24 59 68 36 143 16 33 55 26
2024/20254.342 156 372 226 603 1.271 585 83 323 229 108 197 189
2025/20265.386 560 635 516 341 586 168 672 276 388 383 194 667
2026/2027800 258 129 413 0 0 0 0 0 0 0 0 0
Totale 17.800